FINNENCE ▪ THE WIRE FILE
THE WIRE · № 72071
SEC Filing■ Unclear/unknown
ANET filed 4 on 2026-10-08
KINDSEC Filing
DIRECTION■ Unclear/unknown
SOURCES2
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-08 00:00 UTC
LAST UPDATE2026-10-08 00:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A Form 4 discloses insider transactions but the filing text gives no transaction details, so no directional signal can be read.
Routine insider filing with no actionable detail
CATALYST TO WATCH
Follow-up disclosure of transaction size and price
MAIN RISK
Details may later reveal meaningful insider selling
FULL DISPATCH
ANET (CIK 0001850596) filed a 4 on 2026-10-08.
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
SUBJECTArista Networks · ANET
04 RECEIPTS
THE SOURCE RECORD.
2 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→INFERENCEfilings generate company commentary
New Phase 3 trial: Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne — Sagimet Biosciences Inc.2026-10-07 12:00 UTC
New Phase 3 trial: Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne — Sagimet Biosciences Inc.2026-10-07 12:00 UTC
→INFERENCEfilings generate company commentary
Phase 3 results posted: Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate — Grifols Biologicals, LLC2026-10-07 12:00 UTC
Phase 3 results posted: Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate — Grifols Biologicals, LLC2026-10-07 12:00 UTC
→INFERENCEfilings generate company commentary
Phase 3 results posted: Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers — Sanofi2026-10-07 12:00 UTC
Phase 3 results posted: Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers — Sanofi2026-10-07 12:00 UTC
→INFERENCEfilings generate company commentary
New Phase 3 trial: A Study to Learn the Safety and Efficacy of HLX37 in Combination With Chemotherapy for First-line Treatment in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Shanghai Henlius Biotech2026-10-08 12:00 UTC
New Phase 3 trial: A Study to Learn the Safety and Efficacy of HLX37 in Combination With Chemotherapy for First-line Treatment in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Shanghai Henlius Biotech2026-10-08 12:00 UTC
→INFERENCEfilings generate company commentary
New Phase 3 trial: A Phase 3 Study of Povorcitinib Phosphate in Chinese Adults With Nonsegmental Vitiligo — Dermavon Holdings Limited2026-10-08 12:00 UTC
New Phase 3 trial: A Phase 3 Study of Povorcitinib Phosphate in Chinese Adults With Nonsegmental Vitiligo — Dermavon Holdings Limited2026-10-08 12:00 UTC
→INFERENCEfilings generate company commentary
New Phase 3 trial: Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes — Amgen2026-10-08 12:00 UTC
New Phase 3 trial: Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes — Amgen2026-10-08 12:00 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.